Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study
Srihari Gopal,1 Jagadish Gogate,1 Katalin Pungor,2 Edward Kim,3 Arun Singh,1 Maju Mathews1 1Janssen Research and Development, LLC, Titusville, NJ, USA; 2Medical Affairs, EMEA, Janssen-Cilag, Neuss, Germany; 3Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, USACorrespondence: Srih...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c6dc97ae0664487db7899f4e59a3904f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|